drugset / Trial / NCT00761462

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

NCT00761462

Phase 3 Completed 1029 enrolled Bayer
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.

Timeline

Start
1999-10
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule Oral

Indications